Wexford Capital’s MoonLake Immunotherapeutics MLTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-21,500	Closed	-$840K	–	289
2025 Q1	$840K	Sell	21,500 -2,500	-10%	-$97.7K	0.22%	87
2024 Q4	$1.3M	Buy	24,000 +10,000	+71%	+$542K	0.21%	59
2024 Q3	$706K	Hold	14,000	–	–	0.17%	86
2024 Q2	$616K	Buy	+14,000	New	+$616K	0.16%	94